Position in OGN
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$136,144
-$63,820 QoQ
Shares Held
10,055
-63.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#261
of 626 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wedmont Private Capital holds $55,219,944 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,064 | $19,267,645 | |
| 2 | ABBV |
AbbVie Inc.
|
43,731 | $11,004,468 | |
| 3 | JNJ |
Johnson & Johnson
|
34,052 | $8,648,186 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
32,598 | $4,118,431 | |
| 5 | MRK |
Merck & Co., Inc.
|
28,290 | $3,635,265 | |
| 6 | AMGN |
Amgen Inc
|
8,666 | $3,138,131 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,243 | $1,108,781 | |
| 8 | PFE |
Pfizer Inc
|
41,785 | $1,006,182 |
All Filings in OGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $136,144 | 10,055 | Shares | Sole | 2026-07-13 | |
| 2025-12-31 | $199,964 | 27,889 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,239,499 | 116,058 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,472,502 | 152,118 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $678,343 | 45,557 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,500,041 | 100,539 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $347,534 | 18,167 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $401,207 | 19,382 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $218,606 | 11,628 | Shares | Sole | 2024-04-10 | |
| No filing history on record for this holder in this stock. | ||||||